ADIPOQ and metabolic dysfunction-associated steatohepatitis: The essential roles of adiponectin and its receptors in regulating insulin resistance and lipid metabolism have been well discussed20,27,45, and our observation demonstrated that the adiponectin-based peptide agonist JT003 could reduce liver steatosis in mouse models of NAFLD and NASH.